TILT science presented at the Cancer Immuntherapy and Immunomonitoring (CITIM) conference in Prague in April 2017.
Systemic antitumor effects achieved with adoptive cell therapy-enabling armed oncolytic adenoviruses
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events: